✦ LIBER ✦

S121 Development of a pre-cystectomy model to predict advanced pathological stage in patients with muscle-invasive bladder cancer

✍ Scribed by Stojadinovic, M.; Prelevic, R.; Simic, D.; Spasic, A.; Petrovic, N.

Book ID: 122309004
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 80 KB
Volume: 12
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)62154-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of neoadjuvant erlotini

A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results

✍ Raj S. Pruthi; Matthew Nielsen; Samuel Heathcote; Eric M. Wallen; W. Kim Rathmel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Re: A Phase II Trial of Neoadjuvant Erlo

Re: A Phase II Trial of Neoadjuvant Erlotinib in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: Clinical and Pathological Results

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 62 KB

External Validation of a Risk Model to P

External Validation of a Risk Model to Predict Recurrence-Free Survival After Radical Cystectomy in Patients With Pathological Tumor Stage T3N0 Urothelial Carcinoma of the Bladder

✍ May, Matthias; Bastian, Patrick J.; Brookman-May, Sabine; Fritsche, Hans-Martin; 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 822 KB

Usefulness of the Spanish Urological Clu

Usefulness of the Spanish Urological Club for Oncological Treatment Scoring Model to Predict Nonmuscle Invasive Bladder Cancer Recurrence in Patients Treated With Intravesical Bacillus Calmette-Guérin Plus Interferon-α

✍ Rosevear, Henry M.; Lightfoot, Andrew J.; Nepple, Kenneth G.; O'Donnell, Michael 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 128 KB

786 A randomized, double blind, placebo

786 A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy: An initial report of the EAU Research Foundation randomized phase II clinical trial ‘Magnolia’

✍ Mulders, P.F.A.; Colombel, M.; Heidenreich, A.; Martínez-Piñeiro, L.; Babjuk, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 113 KB

The predictive value of GSTT1 polymorphi

The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non–muscle invasive bladder cancer11Basic Science Research Program, the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2011–0023308) and by a Grant from the Next-Generation BioGreen 21 Program (No. PJ008195), Rural Development Administration, Republic of Korea. The biospecimens for this study were provided by the Chungbuk National University Hospital, a member of the National Biobank of Korea, which is supported by the Ministry of Health, Welfare and Family Affairs. All samples derived from the National Biobank of Korea were obtained with informed consent under institutional review board–approved protocols.

✍ Kang, Ho Won; Tchey, Dong-Un; Yan, Chunri; Kim, Won Tae; Kim, Yong-June; Yun, Se 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 279 KB